254 related articles for article (PubMed ID: 19196889)
1. Assessing glycemic control in maintenance hemodialysis patients with type 2 diabetes.
Kazempour-Ardebili S; Lecamwasam VL; Dassanyake T; Frankel AH; Tam FW; Dornhorst A; Frost G; Turner JJ
Diabetes Care; 2009 Jul; 32(7):1137-42. PubMed ID: 19196889
[TBL] [Abstract][Full Text] [Related]
2. Analysis of hemodialysis-associated hypoglycemia in patients with type 2 diabetes using a continuous glucose monitoring system.
Jung HS; Kim HI; Kim MJ; Yoon JW; Ahn HY; Cho YM; Oh KH; Joo KW; Lee JG; Kim SY; Park KS
Diabetes Technol Ther; 2010 Oct; 12(10):801-7. PubMed ID: 20809681
[TBL] [Abstract][Full Text] [Related]
3. Inter-day glycemic variability assessed by continuous glucose monitoring in insulin-treated type 2 diabetes patients on hemodialysis.
Mirani M; Berra C; Finazzi S; Calvetta A; Radaelli MG; Favareto F; Graziani G; Badalamenti S
Diabetes Technol Ther; 2010 Oct; 12(10):749-53. PubMed ID: 20809678
[TBL] [Abstract][Full Text] [Related]
4. Can the Use of Continuous Glucose Monitoring Improve Glycemic Control in Patients with Type 1 and 2 Diabetes Receiving Dialysis?
Bomholt T; Kofod D; Nørgaard K; Rossing P; Feldt-Rasmussen B; Hornum M
Nephron; 2023; 147(2):91-96. PubMed ID: 35830847
[TBL] [Abstract][Full Text] [Related]
5. Use of continuous glucose monitoring in patients with diabetes on peritoneal dialysis: poor correlation with HbA1c and high incidence of hypoglycaemia.
Oei E; Samad N; Visser A; Chowdhury TA; Fan SL
Diabet Med; 2016 Sep; 33(9):e17-20. PubMed ID: 26470840
[TBL] [Abstract][Full Text] [Related]
6. Improved glycemic control with teneligliptin in patients with type 2 diabetes mellitus on hemodialysis: Evaluation by continuous glucose monitoring.
Wada N; Mori K; Nakagawa C; Sawa J; Kumeda Y; Shoji T; Emoto M; Inaba M
J Diabetes Complications; 2015; 29(8):1310-3. PubMed ID: 26298521
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of self-monitoring of blood glucose versus retrospective continuous glucose monitoring in improving glycaemic control in diabetic kidney disease patients.
Yeoh E; Lim BK; Fun S; Tong J; Yeoh LY; Sum CF; Subramaniam T; Lim SC
Nephrology (Carlton); 2018 Mar; 23(3):264-268. PubMed ID: 27933715
[TBL] [Abstract][Full Text] [Related]
8. Blood glucose fluctuations in hemodialysis patients with end stage diabetic nephropathy.
Jin YP; Su XF; Yin GP; Xu XH; Lou JZ; Chen JJ; Zhou Y; Lan J; Jiang B; Li Z; Lee KO; Ye L; Ma JH
J Diabetes Complications; 2015 Apr; 29(3):395-9. PubMed ID: 25681043
[TBL] [Abstract][Full Text] [Related]
9. Glucose variability in maintenance hemodialysis patients with type 2 diabetes: Comparison of dialysis and nondialysis days.
Bomholt T; Rix M; Almdal T; Knop FK; Rosthøj S; Jørgensen MB; Feldt-Rasmussen B; Hornum M
Hemodial Int; 2023 Apr; 27(2):126-133. PubMed ID: 36760179
[TBL] [Abstract][Full Text] [Related]
10. Glycemic variability in insulin treated type 2 diabetes with well-controlled hemoglobin A1c and its response to further treatment with acarbose.
Su JB; Wang XQ; Chen JF; Wu G; Jin Y
Chin Med J (Engl); 2011 Jan; 124(1):144-7. PubMed ID: 21362322
[TBL] [Abstract][Full Text] [Related]
11. Bicarbonate dialysis compared to hemodiafiltration on glycemic excursions in patients with end-stage renal disease with and without type 2 diabetes mellitus.
Derosa G; Libetta C; Esposito P; Borettaz I; Tinelli C; D'Angelo A; Maffioli P
J Diabetes Complications; 2015; 29(8):1136-41. PubMed ID: 26387810
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Glycemic Markers in Chronic Hemodialysis Using Continuous Glucose Monitoring.
Divani M; Georgianos PI; Didangelos T; Iliadis F; Makedou A; Hatzitolios A; Liakopoulos V; Grekas DM
Am J Nephrol; 2018; 47(1):21-29. PubMed ID: 29275415
[TBL] [Abstract][Full Text] [Related]
13. Assessing glycemic control in maintenance hemodialysis patients with type 2 diabetes: response to Kazempour-Ardebili et al.
Riveline JP; Hadjadj S
Diabetes Care; 2009 Dec; 32(12):e155; author reply e156. PubMed ID: 19940218
[No Abstract] [Full Text] [Related]
14. Glycemic control and extended hemodialysis survival in patients with diabetes mellitus: comparative results of traditional and time-dependent Cox model analyses.
Williams ME; Lacson E; Wang W; Lazarus JM; Hakim R
Clin J Am Soc Nephrol; 2010 Sep; 5(9):1595-601. PubMed ID: 20671217
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of continuous glucose monitoring in dialysis patients with diabetes: the DIALYDIAB pilot study.
Joubert M; Fourmy C; Henri P; Ficheux M; Lobbedez T; Reznik Y
Diabetes Res Clin Pract; 2015 Mar; 107(3):348-54. PubMed ID: 25638452
[TBL] [Abstract][Full Text] [Related]
16. Continuous glucose monitoring in hemodialyzed patients with type 2 diabetes: a multicenter pilot study.
Képénékian L; Smagala A; Meyer L; Imhoff O; Alenabi F; Serb L; Fleury D; Dorey F; Krummel T; Le Floch JP; Chantrel F; Kessler L
Clin Nephrol; 2014 Oct; 82(4):240-6. PubMed ID: 25161114
[TBL] [Abstract][Full Text] [Related]
17. Long-term impact of chronic hemodialysis on glycemic control and serum lipids in insulin-treated type 2-diabetic patients.
Loipl J; Schmekal B; Biesenbach G
Ren Fail; 2005; 27(3):305-8. PubMed ID: 15957547
[TBL] [Abstract][Full Text] [Related]
18. Hemoglobin A1c in hemodialysis patients: should one size fit all?
Ix JH
Clin J Am Soc Nephrol; 2010 Sep; 5(9):1539-41. PubMed ID: 20671219
[No Abstract] [Full Text] [Related]
19. Glycemic control in diabetic dialysis patients and the burnt-out diabetes phenomenon.
Park J; Lertdumrongluk P; Molnar MZ; Kovesdy CP; Kalantar-Zadeh K
Curr Diab Rep; 2012 Aug; 12(4):432-9. PubMed ID: 22638938
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of pioglitazone on type 2 diabetic patients with hemodialysis.
Abe M; Kikuchi F; Okada K; Kaizu K; Matsumoto K
Diabetes Res Clin Pract; 2008 Jun; 80(3):432-8. PubMed ID: 18346811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
